PL1641803T3 - Pochodne tienopirymidyny jako inhibitory kanału potasowego - Google Patents

Pochodne tienopirymidyny jako inhibitory kanału potasowego

Info

Publication number
PL1641803T3
PL1641803T3 PL04736524T PL04736524T PL1641803T3 PL 1641803 T3 PL1641803 T3 PL 1641803T3 PL 04736524 T PL04736524 T PL 04736524T PL 04736524 T PL04736524 T PL 04736524T PL 1641803 T3 PL1641803 T3 PL 1641803T3
Authority
PL
Poland
Prior art keywords
potassium channel
channel inhibitors
thienopyrimidine derivatives
thienopyrimidine
derivatives
Prior art date
Application number
PL04736524T
Other languages
English (en)
Other versions
PL1641803T6 (pl
Inventor
John Ford
Nicholas John Palmer
John Frederick Atherall
David John Madge
Brad Sherborne
Mark Bushfield
Edward Benedict Stevens
Original Assignee
Xention Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0315950.6A external-priority patent/GB0315950D0/en
Application filed by Xention Ltd filed Critical Xention Ltd
Publication of PL1641803T3 publication Critical patent/PL1641803T3/pl
Publication of PL1641803T6 publication Critical patent/PL1641803T6/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL04736524T 2003-06-11 2004-06-10 Pochodne tienopirymidyny jako inhibitory kanału potasowego PL1641803T6 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US47751803P 2003-06-11 2003-06-11
GBGB0315950.6A GB0315950D0 (en) 2003-06-11 2003-06-11 Compounds
PCT/GB2004/002454 WO2004111057A1 (en) 2003-06-11 2004-06-10 Thienopyrimidine derivatives as potassium channel inhibitors
EP04736524A EP1641803B3 (en) 2003-06-11 2004-06-10 Thienopyrimidine derivatives as potassium channel inhibitors

Publications (2)

Publication Number Publication Date
PL1641803T3 true PL1641803T3 (pl) 2009-08-31
PL1641803T6 PL1641803T6 (pl) 2011-04-29

Family

ID=33554173

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04736524T PL1641803T6 (pl) 2003-06-11 2004-06-10 Pochodne tienopirymidyny jako inhibitory kanału potasowego

Country Status (15)

Country Link
EP (1) EP1641803B3 (pl)
KR (1) KR101186678B1 (pl)
CN (1) CN1823071B (pl)
AT (1) ATE425982T1 (pl)
AU (1) AU2004247470B2 (pl)
BR (1) BRPI0411239A (pl)
CA (1) CA2528848C (pl)
DE (1) DE602004020070D1 (pl)
DK (1) DK1641803T3 (pl)
ES (1) ES2324536T7 (pl)
MX (1) MXPA05013549A (pl)
PL (1) PL1641803T6 (pl)
SI (1) SI1641803T1 (pl)
WO (1) WO2004111057A1 (pl)
ZA (1) ZA200600225B (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0315950D0 (en) 2003-06-11 2003-08-13 Xention Discovery Ltd Compounds
MXPA06015223A (es) * 2004-06-29 2007-11-09 Amgen Inc Furanopirimidinas.
US8008487B2 (en) * 2004-10-21 2011-08-30 Dow Agrosciences Llc Substituted thieno[2,3-D]pyrimidines as fungicides
US7576212B2 (en) 2004-12-09 2009-08-18 Xention Limited Thieno[2,3-B] pyridines as potassium channel inhibitors
US7576080B2 (en) 2004-12-23 2009-08-18 Memory Pharmaceuticals Corporation Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors
CN101277939A (zh) 2005-09-09 2008-10-01 布里斯托尔-迈尔斯斯奎布公司 无环ikur抑制剂
GB0525164D0 (en) 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
DE102007027800A1 (de) 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung
US8883852B2 (en) 2008-10-22 2014-11-11 University of Pittburgh—Of the Commonwealth System of Higher Education Radioprotective agents
WO2010103130A2 (en) 2009-03-13 2010-09-16 Katholieke Universiteit Leuven, K.U.Leuven R&D Novel bicyclic heterocycles
EA021113B1 (ru) 2009-09-03 2015-04-30 Бристол-Майерс Сквибб Кампани Хиназолины в качестве ингибиторов калиевых каналов
SG183304A1 (en) * 2010-02-17 2012-09-27 Takeda Pharmaceutical Heterocyclic compound
GB201012889D0 (en) 2010-08-02 2010-09-15 Univ Leuven Kath Antiviral activity of novel bicyclic heterocycles
GB201015411D0 (en) 2010-09-15 2010-10-27 Univ Leuven Kath Anti-cancer activity of novel bicyclic heterocycles
WO2012044993A1 (en) * 2010-09-30 2012-04-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compounds, pharmaceutical compositions, and methods of treating or preventing neurodegenerative diseases or disorders
GB201105659D0 (en) 2011-04-01 2011-05-18 Xention Ltd Compounds
NO3175985T3 (pl) 2011-07-01 2018-04-28
AR090037A1 (es) 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
JP2014533258A (ja) * 2011-11-15 2014-12-11 ゼンション・リミテッドＸｅｎｔｉｏｎ Ｌｉｍｉｔｅｄ カリウムチャネル阻害剤としてのチエノ［２，３−ｃ］ピラゾールの使用
WO2013078126A1 (en) 2011-11-23 2013-05-30 Cancer Research Technology Limited Thienopyrimidine inhibitors of atypical protein kinase c
HK1201455A1 (en) 2012-01-27 2015-09-04 Gilead Sciences Inc Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
WO2014134419A1 (en) 2013-03-01 2014-09-04 Gilead Sciences, Inc. Use of ikach blockers for the treatment of cardiac diseases
CN105339371A (zh) * 2013-03-07 2016-02-17 葛兰素史密斯克莱有限责任公司 作为沉默调节蛋白调节剂的噻吩并[3,2-d]嘧啶-6-甲酰胺和类似物
FR3015483B1 (fr) * 2013-12-23 2016-01-01 Servier Lab Nouveaux derives de thienopyrimidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN106727587A (zh) * 2016-11-28 2017-05-31 李娜 一种治疗心律失常的药物组合物
EA201992780A1 (ru) * 2017-06-21 2020-06-02 ШАЙ ТЕРАПЬЮТИКС ЭлЭлСи Соединения, которые взаимодействуют с суперсемейством ras, для лечения рака, воспалительных заболеваний, ras-опатий и фиброзного заболевания
US12391705B2 (en) 2018-12-19 2025-08-19 Shy Therapeutics, Llc Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD248593A1 (de) * 1985-01-11 1987-08-12 Univ Halle Wittenberg Verfahren zur herstellung von 4-basischsubstituierten thieno/2,3-d/pyrimidin-6-ylcarbonsaeureestern
AU781365B2 (en) * 1999-12-21 2005-05-19 Icagen, Inc. Potassium channel inhibitors
US6566380B2 (en) 2000-07-25 2003-05-20 Icagen, Inc. Potassium channel inhibitors
US6849634B2 (en) 2000-12-21 2005-02-01 Icagen Potassium channel inhibitors

Also Published As

Publication number Publication date
DK1641803T3 (da) 2009-06-29
AU2004247470A1 (en) 2004-12-23
DE602004020070D1 (de) 2010-10-07
KR101186678B1 (ko) 2012-09-27
SI1641803T1 (sl) 2009-08-31
PL1641803T6 (pl) 2011-04-29
EP1641803B3 (en) 2010-12-08
ZA200600225B (en) 2007-04-25
WO2004111057A1 (en) 2004-12-23
EP1641803B1 (en) 2009-03-18
EP1641803A1 (en) 2006-04-05
MXPA05013549A (es) 2006-04-05
ATE425982T1 (de) 2009-04-15
CA2528848C (en) 2012-09-04
CA2528848A1 (en) 2004-12-23
BRPI0411239A (pt) 2006-07-18
ES2324536T3 (es) 2009-08-10
HK1093064A1 (en) 2007-02-23
KR20060057539A (ko) 2006-05-26
CN1823071B (zh) 2012-12-19
AU2004247470B2 (en) 2009-04-23
CN1823071A (zh) 2006-08-23
ES2324536T7 (es) 2012-03-16

Similar Documents

Publication Publication Date Title
MXPA05013549A (es) Derivados de tienopirimidina como inhibidores del canal de potasio.
IL260127B (en) mek inhibitors and methods of using them
SG164368A1 (en) Treatment of cancer
TW200508214A (en) Novel compounds
MY149957A (en) Heterocyclic inhibitors of mek and methods of use thereof
MX2007000490A (es) Analogos de tetrapeptido.
TW200740803A (en) Heterocyclic derivatives as modulators of ion channels
MY161991A (en) Proteasome inhibitors
IL187382A0 (en) Bicyclic derivatives as modulators of ion channels
IL181271A0 (en) Triazolophthalazine derivatives and pharmaceutical compositions containing the same
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
MXPA05014166A (es) Metodos y composiciones para tratar enfermedades relacionadas con amiloide.
CA2603830A1 (en) PYRIDINE [2,3-B] PYRAZINONES
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
WO2006050476A3 (en) Pyrimidine derivatives as ion channel modulators and methods of use
IL205696A0 (en) Heterocyclic derivatives, compositions comprising the same and uses thereof
TW200505443A (en) Combination of SCR kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
EP1551388A4 (en) COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, COMPOSITIONS AND METHODS COMPRISING THE SAME
AU2003270202A8 (en) Pharmaceutical compositions useful for the treatment of cancers
JO3046B1 (ar) اشكال متعددة من 7- )] 3-كلورو-6و11-ثنائي هيدرو -6-ميثيل ثنائي بنزو [1, 2][f,c] ثيازبين-11-يل)امينو[ حمض هباتونك S,S- ثنائي أوكسيد وطرق لتصنيعها و استخدامها.
TW200714284A (en) Novel method
UA96742C2 (en) Mek inhibitors and use thereof
ZA200605653B (en) Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours
MY180594A (en) Proteasome inhibitors